Abstract: The present disclosure relates to a composition for skin improvement and a pharmaceutical composition for preventing or treating an inflammatory skin disease, the compositions including an umbilical cord-derived mesenchymal stem cell culture medium as an active ingredient. The compositions exhibit a wound relief, wrinkle improvement, regeneration, elasticity increase, moisturizing, barrier strengthening, anti-inflammatory or antioxidant effect, and thus can be effectively used as a cosmetic composition for skin improvement or a pharmaceutical composition for preventing or treating an inflammatory skin disease.
Type:
Application
Filed:
November 5, 2021
Publication date:
February 29, 2024
Applicant:
HANS PHARMA CO., LTD.
Inventors:
Na Eun LEE, Jung Tae LEE, Geun Young KIM, Jin Young KIM, Dong Wook KIM, Min Ji LEE, Ro Un LEE